Skip to content
Clinical Trials – home
Emalex Biosciences Inc.
Sponsor

Emalex Biosciences Inc.

United States 330 North Wabash Avenue Suite 3500, 60611-3603, United States

About the sponsor

Emalex Biosciences Inc. concentrates its clinical research on Tourette’s Disorder, with studies spanning children, adolescents, and adults affected by tic-related symptoms.

  • Tic symptom control
  • Maintenance of efficacy
  • Long-term treatment response

The sponsor’s portfolio reflects a focused interest in neurological conditions associated with motor tics and vocal tics, with active research sites across multiple countries.

About Specializations

Emalex Biosciences Inc. runs clinical trials in conditions such as Tourette's disorder, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Tourette's disorder

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years
  • Substances:Ecopipam Hydrochloride
  • Sponsor:Emalex Biosciences Inc.
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ecopipam Hydrochloride
  • Sponsor:Emalex Biosciences Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.